Skip to main content
OpenTrials
Completed

NCT Number: NCT00681382

Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland

This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed persistent asthma
  • regular use of inhaled steroids and concomitant medication

Exclusion criteria

  • never been diagnosed COPD
  • seasonal asthma

Treatment and study plan

Primary outcomes

  1. Patients perceptions about treatment of asthma, asthma medication and what are the most common triggers that cause exacerbations.

    Time frame: Single occasion

Secondary outcomes

  1. How patients react to the first signs of worsening of asthma i.e. how they use asthma medication during stable phase and asthma exacerbation

    Time frame: Single occasion

  2. How asthma affects everyday life

    Time frame: Single occasion

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
May 21, 2008
Registry last updated
Jan 24, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.